Matches in Wikidata for { <http://www.wikidata.org/entity/Q37672731> ?p ?o ?g. }
- Q37672731 description "article científic" @default.
- Q37672731 description "article scientifique" @default.
- Q37672731 description "articolo scientifico" @default.
- Q37672731 description "artigo científico" @default.
- Q37672731 description "artículu científicu espublizáu en 2008" @default.
- Q37672731 description "bilimsel makale" @default.
- Q37672731 description "scientific article published on June 2008" @default.
- Q37672731 description "vedecký článok" @default.
- Q37672731 description "vetenskaplig artikel" @default.
- Q37672731 description "videnskabelig artikel" @default.
- Q37672731 description "vědecký článek" @default.
- Q37672731 description "wetenschappelijk artikel" @default.
- Q37672731 description "wissenschaftlicher Artikel" @default.
- Q37672731 description "наукова стаття, опублікована в червні 2008" @default.
- Q37672731 description "научни чланак" @default.
- Q37672731 description "مقالة علمية نشرت في يونيو 2008" @default.
- Q37672731 name "Antihypertensive effect of zofenopril plus hydrochlorothiazide versus zofenopril monotherapy in patients with essential hypertension according to their cardiovascular risk level: A post hoc analysis" @default.
- Q37672731 name "Antihypertensive effect of zofenopril plus hydrochlorothiazide versus zofenopril monotherapy in patients with essential hypertension according to their cardiovascular risk level: A post hoc analysis" @default.
- Q37672731 name "Antihypertensive effect of zofenopril plus hydrochlorothiazide versus zofenopril monotherapy in patients with essential hypertension according to their cardiovascular risk level: A post hoc analysis." @default.
- Q37672731 type Item @default.
- Q37672731 label "Antihypertensive effect of zofenopril plus hydrochlorothiazide versus zofenopril monotherapy in patients with essential hypertension according to their cardiovascular risk level: A post hoc analysis" @default.
- Q37672731 label "Antihypertensive effect of zofenopril plus hydrochlorothiazide versus zofenopril monotherapy in patients with essential hypertension according to their cardiovascular risk level: A post hoc analysis" @default.
- Q37672731 label "Antihypertensive effect of zofenopril plus hydrochlorothiazide versus zofenopril monotherapy in patients with essential hypertension according to their cardiovascular risk level: A post hoc analysis." @default.
- Q37672731 prefLabel "Antihypertensive effect of zofenopril plus hydrochlorothiazide versus zofenopril monotherapy in patients with essential hypertension according to their cardiovascular risk level: A post hoc analysis" @default.
- Q37672731 prefLabel "Antihypertensive effect of zofenopril plus hydrochlorothiazide versus zofenopril monotherapy in patients with essential hypertension according to their cardiovascular risk level: A post hoc analysis" @default.
- Q37672731 prefLabel "Antihypertensive effect of zofenopril plus hydrochlorothiazide versus zofenopril monotherapy in patients with essential hypertension according to their cardiovascular risk level: A post hoc analysis." @default.
- Q37672731 P1433 Q37672731-2F7952D4-ED76-45BE-8736-F6112BE3D6C2 @default.
- Q37672731 P1476 Q37672731-69BD6891-F0C8-470C-9712-59955DF0EB9B @default.
- Q37672731 P2093 Q37672731-717BC185-96CC-49B9-88CD-EA958D1BFDC3 @default.
- Q37672731 P2093 Q37672731-D200E2D4-2AF3-4C1B-B3B5-FD7B91ABA1DA @default.
- Q37672731 P2860 Q37672731-0E3F57AA-AB6F-4265-A604-F40A6F997471 @default.
- Q37672731 P2860 Q37672731-0EC89A9E-84BB-4373-A498-868FE7C8B6EB @default.
- Q37672731 P2860 Q37672731-124B22F2-CC72-4DCA-AF1B-FE31E247C5CD @default.
- Q37672731 P2860 Q37672731-1DAFBCDD-E17F-458C-9CF9-448B357A39E0 @default.
- Q37672731 P2860 Q37672731-2BDE1C84-4C84-46FC-84A9-F8548B34D405 @default.
- Q37672731 P2860 Q37672731-321B01D4-296A-48A3-8BA6-CD7EFBC06F40 @default.
- Q37672731 P2860 Q37672731-3A212321-411F-43D5-9F8B-6F3EDA1CC323 @default.
- Q37672731 P2860 Q37672731-4292B698-C9C8-4CF7-AAB7-7C1549B0D293 @default.
- Q37672731 P2860 Q37672731-460A57C0-36CF-4A7A-B60F-301F5AEE43EA @default.
- Q37672731 P2860 Q37672731-7319A5FC-BB23-4463-B9A6-AC04340556CB @default.
- Q37672731 P2860 Q37672731-814834C7-34F7-4523-9BDF-256AEBBBB97A @default.
- Q37672731 P2860 Q37672731-818BF08B-001B-4EAC-ABBB-5D8E0270C74B @default.
- Q37672731 P2860 Q37672731-A06A38BE-692B-4400-AC9A-24949DF64D84 @default.
- Q37672731 P2860 Q37672731-A0BB8B04-55F7-4780-B842-38A5ACF72261 @default.
- Q37672731 P2860 Q37672731-A70658F7-66F0-49CD-BFE1-DA54AE9ADFDD @default.
- Q37672731 P2860 Q37672731-A9CB8F71-580A-411F-8EDF-EACAC913826B @default.
- Q37672731 P2860 Q37672731-B4B044A0-AB6F-48D6-884F-32F877625042 @default.
- Q37672731 P2860 Q37672731-B57E5362-5341-4B30-83CC-8DA542883261 @default.
- Q37672731 P2860 Q37672731-BE3546F6-0D5E-4AB2-8128-353661EC3964 @default.
- Q37672731 P2860 Q37672731-C0B44106-1D9B-4941-8BBA-6BE503FB8162 @default.
- Q37672731 P2860 Q37672731-C4591DD5-B0E8-40C1-AC66-BB373A856952 @default.
- Q37672731 P2860 Q37672731-CD30E11A-89AA-4F2E-B2F4-D421C4C35630 @default.
- Q37672731 P304 Q37672731-29DF4F28-5806-447C-8687-18485F22637C @default.
- Q37672731 P31 Q37672731-BD50B39E-33ED-4F3E-B4AB-4527B8F537CD @default.
- Q37672731 P356 Q37672731-D12536BE-AF59-48AB-8A47-F7101F374C24 @default.
- Q37672731 P433 Q37672731-15D25B8B-10CF-41CF-ADF7-986A084E023F @default.
- Q37672731 P478 Q37672731-B47B3894-C856-4C50-B3A0-742CB9614EFD @default.
- Q37672731 P50 Q37672731-B5629E8A-180C-4C8A-A656-83202D533BED @default.
- Q37672731 P577 Q37672731-17178748-9B9E-49A2-8E69-AFCFF99AD0D7 @default.
- Q37672731 P5875 Q37672731-EA525FC8-B8E7-4CA4-A919-F797103CED5D @default.
- Q37672731 P698 Q37672731-4EF1ED92-9B65-4B16-B6B3-8A59FF5D465C @default.
- Q37672731 P921 Q37672731-2341D96B-4956-4188-9617-B851DD51FD2A @default.
- Q37672731 P921 Q37672731-6C23FE74-38A4-4B06-A140-1228DC2B6514 @default.
- Q37672731 P932 Q37672731-1AB35F3F-BDDF-436C-B7C6-35936C2A2657 @default.
- Q37672731 P356 J.CURTHERES.2008.06.008 @default.
- Q37672731 P698 24692801 @default.
- Q37672731 P1433 Q15752574 @default.
- Q37672731 P1476 "Antihypertensive effect of zofenopril plus hydrochlorothiazide versus zofenopril monotherapy in patients with essential hypertension according to their cardiovascular risk level: A post hoc analysis" @default.
- Q37672731 P2093 "Ettore Malacco" @default.
- Q37672731 P2093 "Study Group" @default.
- Q37672731 P2860 Q28204197 @default.
- Q37672731 P2860 Q29618529 @default.
- Q37672731 P2860 Q34327991 @default.
- Q37672731 P2860 Q34360720 @default.
- Q37672731 P2860 Q34397454 @default.
- Q37672731 P2860 Q34534248 @default.
- Q37672731 P2860 Q34577493 @default.
- Q37672731 P2860 Q36514166 @default.
- Q37672731 P2860 Q36548189 @default.
- Q37672731 P2860 Q44270421 @default.
- Q37672731 P2860 Q44412916 @default.
- Q37672731 P2860 Q44453232 @default.
- Q37672731 P2860 Q44950901 @default.
- Q37672731 P2860 Q46888928 @default.
- Q37672731 P2860 Q47873598 @default.
- Q37672731 P2860 Q56970780 @default.
- Q37672731 P2860 Q57012239 @default.
- Q37672731 P2860 Q57490328 @default.
- Q37672731 P2860 Q57570829 @default.
- Q37672731 P2860 Q70754440 @default.
- Q37672731 P2860 Q73472570 @default.
- Q37672731 P2860 Q81275334 @default.
- Q37672731 P304 "232-242" @default.
- Q37672731 P31 Q13442814 @default.
- Q37672731 P356 "10.1016/J.CURTHERES.2008.06.008" @default.
- Q37672731 P433 "3" @default.
- Q37672731 P478 "69" @default.
- Q37672731 P50 Q37830581 @default.
- Q37672731 P577 "2008-06-01T00:00:00Z" @default.
- Q37672731 P5875 "235331964" @default.